ADVFN US – Market Content Editor

Armata Pharmaceuticals (AMEX:ARMP) shares rose 8% after the company said the US Food and Drug Administration granted Breakthrough Therapy designation to AP-SA02, its intravenously administered Staphylococcus aureus multi-phage product candidate. The designation covers AP-SA02 as an adjunct treatment for complicated bacteremia caused by methicillin-sensitive S. aureus, or MSSA, and methicillin-resistant S. aureus, or MRSA. FDA…

Corteva (NYSE:CTVA) said its board has approved the separation of the company’s seed operating segment into an independent, publicly traded company named Vylor Inc. Vylor is expected to list on the New York Stock Exchange under the ticker symbol VYLR following completion of the separation. Corteva shareholders of record at the close of business on…

Definium Therapeutics, Inc. (NASDAQ:DFTX) shares rose 20% after the company reported topline results from its Phase 3 Panorama study evaluating DT120 ODT in patients with generalized anxiety disorder. The study met its primary endpoint and all key secondary efficacy endpoints. Participants receiving DT120 ODT 100 µg showed a statistically significant reduction in Hamilton Anxiety Rating…

Largo Inc. (NASDAQ:LGO) announced a series of financing, operational and commercial updates, including a debt-restructuring agreement with Caixa Econômica Federal and its first sales of copper-platinum group metals concentrate. The company also said its 2026 vanadium production is now expected to be at the lower end of its previously announced guidance range as it temporarily…

Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP) shares rose 12% on Monday after the company reported topline results from its CANYON-1 Phase 1b clinical trial evaluating CRB-913 as a treatment for obesity. The study showed statistically significant mean weight loss compared with placebo across all three doses tested, with the highest 60 mg dose producing mean weight…

Stellantis (NYSE:STLA) shares fell more than 2% on Monday after Morgan Stanley downgraded the automaker to Underweight from Equal Weight and reduced its price target to $5.20 from $8.00. The rating change formed part of a broader review of European automakers by analysts led by Javier Martinez de Olcoz Cerdan. The analysts cited changes in…

The Elmet Group Co. (NASDAQ:ELMT) said on September 14, 2026, that the US Department of War has committed to invest $450 million in the company to expand domestic tungsten manufacturing and international mining capacity. The investment will begin with an initial $200 million drawdown at closing, followed by additional drawdowns. In return, the department will…

Olema Pharmaceuticals (NASDAQ:OLMA) shares fell 15.1% in pre-market trading to $8.68 after AstraZeneca reported that its Phase 3 SERENA-4 trial of camizestrant did not meet its primary endpoint. AstraZeneca said on Friday that camizestrant, in combination with palbociclib, did not demonstrate a statistically significant improvement in progression-free survival as a first-line treatment for patients with…